- Home
- ILLR vs CYRX Comparison
ILLR vs CYRX Comparison
Compare ILLR & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILLR
- CYRX
- Stock Information
- Founded
- ILLR 2015
- CYRX 1999
- Country
- ILLR United States
- CYRX United States
- Employees
- ILLR N/A
- CYRX N/A
- Industry
- ILLR Investment Managers
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- ILLR Finance
- CYRX Health Care
- Exchange
- ILLR Nasdaq
- CYRX Nasdaq
- Market Cap
- ILLR 369.3M
- CYRX 422.6M
- IPO Year
- ILLR N/A
- CYRX N/A
- Fundamental
- Price
- ILLR $1.90
- CYRX $8.16
- Analyst Decision
- ILLR
- CYRX Buy
- Analyst Count
- ILLR 0
- CYRX 7
- Target Price
- ILLR N/A
- CYRX $13.14
- AVG Volume (30 Days)
- ILLR 947.0K
- CYRX 261.6K
- Earning Date
- ILLR 02-15-2025
- CYRX 03-11-2025
- Dividend Yield
- ILLR N/A
- CYRX N/A
- EPS Growth
- ILLR N/A
- CYRX N/A
- EPS
- ILLR N/A
- CYRX N/A
- Revenue
- ILLR $45,244,000.00
- CYRX $226,113,000.00
- Revenue This Year
- ILLR N/A
- CYRX N/A
- Revenue Next Year
- ILLR N/A
- CYRX $7.70
- P/E Ratio
- ILLR N/A
- CYRX N/A
- Revenue Growth
- ILLR N/A
- CYRX N/A
- 52 Week Low
- ILLR $0.66
- CYRX $5.32
- 52 Week High
- ILLR $8.86
- CYRX $20.11
- Technical
- Relative Strength Index (RSI)
- ILLR N/A
- CYRX 53.74
- Support Level
- ILLR N/A
- CYRX $6.97
- Resistance Level
- ILLR N/A
- CYRX $8.97
- Average True Range (ATR)
- ILLR 0.00
- CYRX 0.55
- MACD
- ILLR 0.00
- CYRX -0.08
- Stochastic Oscillator
- ILLR 0.00
- CYRX 59.50
About ILLR Triller Group Inc. Common Stock
Triller Group Inc is a us-based company that operates its businesses through Triller Corp which operates as a technology platform and AGBA Group Holding Limited operates as an insurance and wealth distribution platform.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.